An Observational Longitudinal Oligo-Center Study to Define Clinical Biofluid Imaging and Digital Outcome Measures in Multiple System Atrophy
Brief description of study
This research study is an observational, non-interventional, study to define changes in clinical, neurological, blood, spinal fluid, and neuroimaging (MRI) biomarkers (A biomarker is a measurable substance which indicates the presence of a disease and or change in the disease state over time) in patients with multiple system atrophy (MSA) comparing baseline to 6-month and 1-year assessments.
Clinical Study Identifier: s19-01846
ClinicalTrials.gov Identifier: NCT04450992
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
